Related Experiment Video
Updated: Jun 17, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt
Futoshi Suizu1, Yosuke Hiramuki, Fumihiko Okumura
1Division of Cancer Biology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.
Abstract:
The serine threonine kinase Akt is a core survival factor that underlies a variety of human diseases. Although regulatory phosphorylation and dephosphorylation have been well documented, the other posttranslational mechanisms that modulate Akt activity remain unclear. We show here that tetratricopeptide repeat domain 3 (TTC3) is an E3 ligase that interacts with Akt. TTC3 contains a canonical RING finger motif, a pair of tetratricopeptide motifs, a putative Akt phosphorylation site, and nuclear localization signals, and is encoded by a gene within the Down syndrome (DS) critical region on chromosome 21. TTC3 is an Akt-specific E3 ligase that binds to phosphorylated Akt and facilitates its ubiquitination and degradation within the nucleus. Moreover, DS cells exhibit elevated TTC3 expression, reduced phosphorylated Akt, and accumulation in the G(2)M phase, which can be reversed by TTC3 siRNA or Myr-Akt. Thus, interaction between TTC3 and Akt may contribute to the clinical symptoms of DS.
Insights
Tetratricopeptide repeat domain 3 (TTC3) acts as an E3 ligase, targeting the survival factor Akt for degradation. This interaction, elevated in Down syndrome (DS) cells, may contribute to DS symptoms.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- The serine/threonine kinase Akt is a crucial survival factor implicated in numerous human diseases.
- While phosphorylation regulates Akt, other post-translational modifications influencing its activity are not well understood.
Purpose of the Study:
- To investigate novel post-translational mechanisms modulating Akt activity.
- To identify and characterize the function of tetratricopeptide repeat domain 3 (TTC3) in relation to Akt.
Main Methods:
- Protein interaction studies to confirm TTC3 and Akt binding.
- Ubiquitination assays to assess Akt modification by TTC3.
- Cellular studies using siRNA and Akt activators in Down syndrome (DS) cell models.
Main Results:
- Tetratricopeptide repeat domain 3 (TTC3) identified as an Akt-specific E3 ligase.
- TTC3 binds to phosphorylated Akt, promoting its ubiquitination and nuclear degradation.
- DS cells show increased TTC3, decreased phosphorylated Akt, and G2M cell cycle arrest, reversible by TTC3 inhibition or Akt activation.
Conclusions:
- TTC3-mediated Akt degradation is a novel regulatory pathway.
- The interaction between TTC3 and Akt may play a role in the pathophysiology of Down syndrome.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
PI3K/mTOR/AKT Signaling Pathway
Anaphase Promoting Complex
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

